DK3482754T3 - Farmaceutiske sammensætninger og anvendelser rettet mod lysosomale lagringssygdomme - Google Patents
Farmaceutiske sammensætninger og anvendelser rettet mod lysosomale lagringssygdomme Download PDFInfo
- Publication number
- DK3482754T3 DK3482754T3 DK18210763.1T DK18210763T DK3482754T3 DK 3482754 T3 DK3482754 T3 DK 3482754T3 DK 18210763 T DK18210763 T DK 18210763T DK 3482754 T3 DK3482754 T3 DK 3482754T3
- Authority
- DK
- Denmark
- Prior art keywords
- pharmaceutical compositions
- lysosomal storage
- storage diseases
- applications targeted
- targeted
- Prior art date
Links
- 208000015439 Lysosomal storage disease Diseases 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/45—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
- C07C233/46—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1613828.1A GB201613828D0 (en) | 2016-08-11 | 2016-08-11 | Therapeutic agents for lysosomal storage disorders |
| GBGB1702552.9A GB201702552D0 (en) | 2017-02-16 | 2017-02-16 | Therapeutic agents for lysosomal storage disorders |
| GBGB1705762.1A GB201705762D0 (en) | 2017-04-10 | 2017-04-10 | Therapeutic agents for lysosomal storage disorders |
| GBGB1706854.5A GB201706854D0 (en) | 2017-04-28 | 2017-04-28 | Therapeutic agents for lysosomal storage disorders |
| EP17767933.9A EP3359146B1 (en) | 2016-08-11 | 2017-08-11 | Pharmaceutical compositions and uses directed to lysosomal storage disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3482754T3 true DK3482754T3 (da) | 2021-02-01 |
Family
ID=59859423
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK17767933.9T DK3359146T3 (da) | 2016-08-11 | 2017-08-11 | Farmaceutiske sammensætninger og anvendelser rettet mod lysosomale lagringssygdomme |
| DK18210763.1T DK3482754T3 (da) | 2016-08-11 | 2017-08-11 | Farmaceutiske sammensætninger og anvendelser rettet mod lysosomale lagringssygdomme |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK17767933.9T DK3359146T3 (da) | 2016-08-11 | 2017-08-11 | Farmaceutiske sammensætninger og anvendelser rettet mod lysosomale lagringssygdomme |
Country Status (28)
| Country | Link |
|---|---|
| US (2) | US11400067B2 (da) |
| EP (4) | EP3865126A1 (da) |
| JP (3) | JP7393943B2 (da) |
| KR (3) | KR102412724B1 (da) |
| CN (1) | CN109843275A (da) |
| AU (2) | AU2017308864B2 (da) |
| BR (1) | BR112019002719A2 (da) |
| CA (1) | CA3033557A1 (da) |
| CY (2) | CY1121345T1 (da) |
| DK (2) | DK3359146T3 (da) |
| ES (2) | ES2849566T3 (da) |
| HK (1) | HK1253282B (da) |
| HR (2) | HRP20190344T1 (da) |
| HU (2) | HUE041914T2 (da) |
| IL (1) | IL264610A (da) |
| LT (2) | LT3359146T (da) |
| MA (2) | MA55947A (da) |
| MD (2) | MD3482754T2 (da) |
| ME (1) | ME03340B (da) |
| MX (2) | MX2019001577A (da) |
| PL (2) | PL3482754T3 (da) |
| PT (2) | PT3359146T (da) |
| RS (2) | RS58478B1 (da) |
| RU (2) | RU2749515C2 (da) |
| SG (1) | SG11201901048VA (da) |
| SI (2) | SI3359146T1 (da) |
| TN (1) | TN2019000032A1 (da) |
| WO (1) | WO2018029657A1 (da) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112019002719A2 (pt) * | 2016-08-11 | 2019-05-14 | Intrabio Ltd | acetil-leucina, ou um sal farmaceuticamente aceitável da mesma, para uso em métodos relacionados a doenças de depósito lisossômico |
| GB201709459D0 (en) | 2017-06-14 | 2017-07-26 | Intrabio Ltd | Treatment for migraine |
| US20220024858A1 (en) * | 2018-12-06 | 2022-01-27 | Intrabio Ltd. | Deuterated analogs of acetyl-leucine |
| CA3131948A1 (en) | 2019-03-02 | 2020-09-10 | Intrabio Ltd. | Leucine, acetyl leucine, and related analogs for treating disease |
| US20220362189A1 (en) | 2019-06-28 | 2022-11-17 | Intrabio Ltd. | Combination therapy with acetyl-leucine and miglustat |
| WO2022264037A1 (en) * | 2021-06-14 | 2022-12-22 | Intrabio Ltd. | Branched-chain amino acid derivatives to treat disease |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2749512B1 (fr) * | 1996-06-10 | 1999-08-13 | Pf Medicament | Utilisation de l'acetyl dl leucine pour le traitement des tremblements |
| US20020095135A1 (en) | 2000-06-19 | 2002-07-18 | David Meeker | Combination enzyme replacement, gene therapy and small molecule therapy for lysosomal storage diseases |
| FR2883180B1 (fr) * | 2005-03-18 | 2007-05-25 | Pierre Fabre Medicament Sa | Utilisation de l'acetyl-leucine pour la preparation d'un medicament destine au traitement de troubles de l'equilibre |
| FR2905600B1 (fr) * | 2006-09-13 | 2010-01-15 | Pf Medicament | Traitement des vertiges par l'acetyl-l-leucine. |
| WO2009114729A2 (en) * | 2008-03-14 | 2009-09-17 | Irm Llc | Compounds, compositions and methods for treating lysosomal storage diseases and disorders |
| TN2010000251A1 (fr) * | 2010-06-03 | 2011-11-11 | Rekik Raouf | N-acetyl-dl-leucine medicament neuro et retino protecteur |
| GB201114017D0 (en) | 2011-08-15 | 2011-09-28 | Univ Dundee | Inhibitors against endosomal/ysosomal enzymes |
| WO2013182652A1 (en) * | 2012-06-06 | 2013-12-12 | Fondazione Telethon | Allosteric chaperones and uses thereof |
| US20200179320A1 (en) * | 2016-08-11 | 2020-06-11 | Intrabio Limited | Therapeutic agents for neurodegenerative diseases |
| BR112019002719A2 (pt) * | 2016-08-11 | 2019-05-14 | Intrabio Ltd | acetil-leucina, ou um sal farmaceuticamente aceitável da mesma, para uso em métodos relacionados a doenças de depósito lisossômico |
-
2017
- 2017-08-11 BR BR112019002719-0A patent/BR112019002719A2/pt active Search and Examination
- 2017-08-11 KR KR1020197007024A patent/KR102412724B1/ko active IP Right Grant
- 2017-08-11 MD MDE20190593T patent/MD3482754T2/ro unknown
- 2017-08-11 PT PT17767933T patent/PT3359146T/pt unknown
- 2017-08-11 EP EP20215877.0A patent/EP3865126A1/en active Pending
- 2017-08-11 SG SG11201901048VA patent/SG11201901048VA/en unknown
- 2017-08-11 MD MDE20181131T patent/MD3359146T2/ro unknown
- 2017-08-11 MX MX2019001577A patent/MX2019001577A/es unknown
- 2017-08-11 ME MEP-2019-60A patent/ME03340B/me unknown
- 2017-08-11 KR KR1020227039341A patent/KR20220154849A/ko not_active IP Right Cessation
- 2017-08-11 EP EP18210763.1A patent/EP3482754B1/en active Active
- 2017-08-11 DK DK17767933.9T patent/DK3359146T3/da active
- 2017-08-11 PL PL18210763T patent/PL3482754T3/pl unknown
- 2017-08-11 TN TNP/2019/000032A patent/TN2019000032A1/en unknown
- 2017-08-11 MA MA055947A patent/MA55947A/fr unknown
- 2017-08-11 US US16/324,301 patent/US11400067B2/en active Active
- 2017-08-11 LT LTEP17767933.9T patent/LT3359146T/lt unknown
- 2017-08-11 CA CA3033557A patent/CA3033557A1/en active Pending
- 2017-08-11 RU RU2019106493A patent/RU2749515C2/ru active
- 2017-08-11 ES ES18210763T patent/ES2849566T3/es active Active
- 2017-08-11 HU HUE17767933A patent/HUE041914T2/hu unknown
- 2017-08-11 DK DK18210763.1T patent/DK3482754T3/da active
- 2017-08-11 RS RS20190334A patent/RS58478B1/sr unknown
- 2017-08-11 AU AU2017308864A patent/AU2017308864B2/en active Active
- 2017-08-11 SI SI201730032T patent/SI3359146T1/sl unknown
- 2017-08-11 EP EP24154769.4A patent/EP4342461A3/en active Pending
- 2017-08-11 LT LTEP18210763.1T patent/LT3482754T/lt unknown
- 2017-08-11 KR KR1020227009897A patent/KR102467953B1/ko active IP Right Grant
- 2017-08-11 MA MA43876A patent/MA43876B1/fr unknown
- 2017-08-11 SI SI201730613T patent/SI3482754T1/sl unknown
- 2017-08-11 WO PCT/IB2017/054928 patent/WO2018029657A1/en active Application Filing
- 2017-08-11 EP EP17767933.9A patent/EP3359146B1/en active Active
- 2017-08-11 RS RS20210064A patent/RS61442B1/sr unknown
- 2017-08-11 RU RU2021115932A patent/RU2021115932A/ru unknown
- 2017-08-11 JP JP2019507811A patent/JP7393943B2/ja active Active
- 2017-08-11 HU HUE18210763A patent/HUE052837T2/hu unknown
- 2017-08-11 PL PL17767933T patent/PL3359146T3/pl unknown
- 2017-08-11 CN CN201780062740.XA patent/CN109843275A/zh active Pending
- 2017-08-11 PT PT182107631T patent/PT3482754T/pt unknown
- 2017-08-11 ES ES17767933T patent/ES2716133T3/es active Active
-
2018
- 2018-10-02 HK HK18112571.2A patent/HK1253282B/zh unknown
-
2019
- 2019-02-03 IL IL264610A patent/IL264610A/en unknown
- 2019-02-07 MX MX2021008432A patent/MX2021008432A/es unknown
- 2019-02-21 HR HRP20190344TT patent/HRP20190344T1/hr unknown
- 2019-03-08 CY CY20191100279T patent/CY1121345T1/el unknown
-
2021
- 2021-01-12 CY CY20211100017T patent/CY1123844T1/el unknown
- 2021-01-29 HR HRP20210153TT patent/HRP20210153T1/hr unknown
-
2022
- 2022-01-07 JP JP2022001694A patent/JP2022050564A/ja active Pending
- 2022-06-30 US US17/854,027 patent/US20220331278A1/en active Pending
-
2023
- 2023-05-10 AU AU2023202903A patent/AU2023202903A1/en active Pending
-
2024
- 2024-02-27 JP JP2024027864A patent/JP2024059863A/ja active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3565550T3 (da) | Farmaceutiske sammensætninger omfattende meloxicam og rizatriptan | |
| DK3354282T3 (da) | Glycan-terapeutiske midler og relaterede fremgangsmåder deraf | |
| DK3529248T3 (da) | Farmaceutiske sammensætninger | |
| DK3357513T3 (da) | Farmaceutisk sammensætning og anvendelse deraf | |
| DK3482754T3 (da) | Farmaceutiske sammensætninger og anvendelser rettet mod lysosomale lagringssygdomme | |
| DK3079725T3 (da) | Administration, brug og terapeutiske anvendelser af crispr-cas-systemerne og sammensætninger til genomredigering | |
| MA50541A (fr) | Formulations pharmaceutiques | |
| DK3102200T3 (da) | Terapeutisk forbindelse og sammensætning | |
| MA41794A (fr) | Agents thérapeutiques modifiés et compositions associées | |
| DK3263565T3 (da) | Cyklisk aminderivat og farmaceutisk anvendelse deraf | |
| DK3412660T3 (da) | Sulfonamidderivat og farmaceutisk sammensætning indeholdende samme | |
| DK3334500T3 (da) | Multiligand-lægemiddelskonjugater og anvendelser deraf | |
| MA42303A (fr) | Formulations pharmaceutiques | |
| DK3255042T3 (da) | Heterocyklisk forbindelse og farmaceutisk sammensætning omfattende samme | |
| MA46867A (fr) | Formulations pharmaceutiques | |
| DK3223796T3 (da) | Farmaceutiske sammensætninger, fremstilling og anvendelser deraf | |
| DK3634377T3 (da) | Farmaceutisk formulering | |
| DK3409660T3 (da) | Cyklisk aminderivat og farmaceutisk anvendelse deraf | |
| DK3709978T3 (da) | Farmaceutisk oral formulering omfattende bakterier | |
| DK3821905T3 (da) | Insulin indeholdende farmaceutiske sammensætninger | |
| MA44987A (fr) | Formulations de médicaments améliorées | |
| DK3302543T3 (da) | Vaccinesammensætninger mod porcint reproduktions- og respirationssyndrom og porcint circovirus-associerede sygdomme | |
| DK3231793T3 (da) | Dihydropyromidin-2-on-forbindelser og medicinske anvendelser deraf | |
| BR112017013012A2 (pt) | compostos de indenil, composições farmacêuticas e usos médicos destes | |
| MA49837A (fr) | Compositions pharmaceutiques |